Seoulin Bioscience Co.Ltd - Asset Resilience Ratio

Latest as of December 2025: 20.42%

Seoulin Bioscience Co.Ltd (038070) has an Asset Resilience Ratio of 20.42% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Seoulin Bioscience Co.Ltd (038070) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩24.26 Billion
≈ $16.44 Million USD Cash + Short-term Investments

Total Assets

₩118.80 Billion
≈ $80.51 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Seoulin Bioscience Co.Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Seoulin Bioscience Co.Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Seoulin Bioscience Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Seoulin Bioscience Co.Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩24.26 Billion 20.42%
Total Liquid Assets ₩24.26 Billion 20.42%

Asset Resilience Insights

  • Good Liquidity Position: Seoulin Bioscience Co.Ltd maintains a healthy 20.42% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Seoulin Bioscience Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Seoulin Bioscience Co.Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Spyre Therapeutics Inc.
NASDAQ:SYRE
Biotechnology 84.34%
3SBio Inc
F:83B
Biotechnology 10.64%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
Biotechnology 0.02%
Novavax Inc
NASDAQ:NVAX
Biotechnology 53.87%
BB Biotech AG
SW:BION
Biotechnology 0.05%

Annual Asset Resilience Ratio for Seoulin Bioscience Co.Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Seoulin Bioscience Co.Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 20.42% ₩24.26 Billion
≈ $16.44 Million
₩118.80 Billion
≈ $80.51 Million
-1.59pp
2024-12-31 22.02% ₩22.36 Billion
≈ $15.15 Million
₩101.52 Billion
≈ $68.80 Million
-6.79pp
2023-12-31 28.81% ₩32.88 Billion
≈ $22.28 Million
₩114.10 Billion
≈ $77.32 Million
-10.33pp
2022-12-31 39.14% ₩52.79 Billion
≈ $35.78 Million
₩134.87 Billion
≈ $91.40 Million
-14.52pp
2021-12-31 53.66% ₩73.28 Billion
≈ $49.66 Million
₩136.57 Billion
≈ $92.55 Million
+29.56pp
2020-12-31 24.10% ₩18.86 Billion
≈ $12.78 Million
₩78.25 Billion
≈ $53.03 Million
-3.21pp
2019-12-31 27.30% ₩22.04 Billion
≈ $14.93 Million
₩80.71 Billion
≈ $54.69 Million
+13.63pp
2018-12-31 13.68% ₩9.73 Billion
≈ $6.59 Million
₩71.11 Billion
≈ $48.19 Million
-1.55pp
2017-12-31 15.23% ₩10.82 Billion
≈ $7.33 Million
₩71.04 Billion
≈ $48.14 Million
-9.54pp
2016-12-31 24.77% ₩16.46 Billion
≈ $11.16 Million
₩66.47 Billion
≈ $45.05 Million
-4.59pp
2015-12-31 29.36% ₩19.41 Billion
≈ $13.15 Million
₩66.10 Billion
≈ $44.80 Million
-2.45pp
2014-12-31 31.81% ₩19.32 Billion
≈ $13.09 Million
₩60.72 Billion
≈ $41.15 Million
-1.62pp
2013-12-31 33.44% ₩20.19 Billion
≈ $13.68 Million
₩60.39 Billion
≈ $40.92 Million
--
pp = percentage points

About Seoulin Bioscience Co.Ltd

KQ:038070 Korea Biotechnology
Market Cap
$30.03 Million
₩44.31 Billion KRW
Market Cap Rank
#23814 Global
#1629 in Korea
Share Price
₩5020.00
Change (1 day)
-3.09%
52-Week Range
₩4820.00 - ₩7990.00
All Time High
₩36786.63
About

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and fun… Read more